Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Autologous 111 Indium-Oxinate-Labelled Platelet Sequestration Study in Patients with Immune Thrombocytopenia Treated By Thrombopoietic Receptor-Agonists

Blood (2016) 128 (22): 2555.

https://doi.org/10.1182/blood.V128.22.2555.2555

Published: 2016

Journal Articles

Portal or Splenic Vein Thrombosis after Splenectomy for Immune Cytopenia: A Retrospective Cohort Study

Caroline Morbieu, Francesco Brunetti, MD, Laurence Baranès, MD, Laetitia Languille, Nicolas Limal, MD, Valentine Loustau, MD, Philippe Bierling, MD PhD, Marc Michel, MD, Bertrand Godeau, MD PhD, Matthieu Mahévas, MD PhD

Blood (2015) 126 (23): 3483.

https://doi.org/10.1182/blood.V126.23.3483.3483

Published: 2015

Journal Articles

Impact of Pregnancy On the Course of Immune Thrombocytopenic Purpura: An Observational Study On 44 Cases.

Lilia Baili, Mehdi Khellaf, Laetitia Languille, Philippe Bierling, MD, PhD, Bertrand Godeau, Marc Michel

Blood (2009) 114 (22): 1320.

https://doi.org/10.1182/blood.V114.22.1320.1320

Published: 2009

Journal Articles

Hydroxychloroquine for the Treatment of Immune Thrombocytopenia Associated with Antinuclear Antibody in Patients Refractory to First-Line treatments .

Amélie Chabrol, Matthieu Mahévas, Nicolas Limal, Medhi Khellaf, Philippe Bierling, MD, PhD, Marc Michel, Bertrand Godeau

Blood (2009) 114 (22): 2414.

https://doi.org/10.1182/blood.V114.22.2414.2414

Published: 2009

Journal Articles

Costs of Managing Chronic Immune Thrombocytopenic Purpura (ITP) in Adults: A Retrospective Analysis.

Mehdi Khellaf, Laurent Eckert, Priscille Poitrinal, Camille Francesconi, Albert Haddad, Laetitia Languille, Philippe Bierling, MD, PhD, Marc Michel, Lionel Riou França, Robert Launois, Bertrand Godeau

Blood (2009) 114 (22): 4462.

https://doi.org/10.1182/blood.V114.22.4462.4462

Published: 2009

Journal Articles

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the “real-life” : Result of the French Experience in 72 Adults.

Blood (2009) 114 (22): 3519.

https://doi.org/10.1182/blood.V114.22.3519.3519

Published: 2009

Journal Articles

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Ruben Nzouakou, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2008) 112 (11): 3037.

https://doi.org/10.1182/blood.V112.11.3037.3037

Published: 2008

Journal Articles

The Organization of the National Blood Bank for Rare Blood Units in France

Anne Fialaire-Legendre, Pharm.D, PhD, Btissam Chami, Pharm.D, PhD, Thierry Peyrard, Pharm.D, Pierre-Yves Le Pennec, MD, Philippe Bierling, MD, PhD, France Noizat-Pirenne, MD, PhD

Blood (2008) 112 (11): 3039.

https://doi.org/10.1182/blood.V112.11.3039.3039

Published: 2008

Journal Articles

Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.

France Noizat-Pirenne, MD, PhD, Philippe Chadebech, PhD, Marc Michel, MD, Dora Bachir, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2007) 110 (11): 2904.

https://doi.org/10.1182/blood.V110.11.2904.2904

Published: 2007

Journal Articles

Prevalence and Clinical Significance of Elevated Antiphospholipid Antibodies in Adults with Immune Thrombocytopenic Purpura.

Carole Pierrot-Deseilligny, MD, Mehdi Khellaf, MD, Michele Gouault, MD, PhD, Liliane Intrator, MD, PhD, Marc Michel, MD, Philippe Bierling, MD, PhD, Bertrand Godeau, MD

Blood (2006) 108 (11): 1083.

https://doi.org/10.1182/blood.V108.11.1083.1083

Published: 2006

Journal Articles

Rituximab Is an Alternative to Splenectomy in Adults with Chronic Immune Thrombocytopenic Purpura: Results of a Multicenter Prospective Phase 2 Study.

Bertrand Godeau, MD, Olivier Fain, MD, Raphael Porcher, MD, PhD, Francois Lefrere, MD, Pierre Fenaux, MD, PhD, Stephane Cheze, MD, Anne Vekhoff, MD, Marie-Paule Chauveheid, MD, Jerome Stirnemann, MD, Lionel Galicier, MD, Emmanuelle Bourgeois, MD, Stephanie Haiat, MD, Bruno Varet, MD, Michel Leporrier, MD, Thomas Papo, MD, Marc Michel, MD, Philippe Bierling, MD, PhD

Blood (2006) 108 (11): 478.

https://doi.org/10.1182/blood.V108.11.478.478

Published: 2006

Journal Articles

Relative Immunogenicity of Fy a and K Antigens Based on HLA Class II Restriction Analysis.

Helene Ansart-Pirenne, MD, PhD, Christophe Tournamille, PhD, Philippe Bierling, MD, PhD, Francoise Roudot-Thoraval, MD, PhD, Pierre-Yves Le Pennec, MD, Philippe Rouger, MD, PhD, France Noizat-pirenne, MD, PhD

Blood (2005) 106 (11): 432.

https://doi.org/10.1182/blood.V106.11.432.432

Published: 2005

Journal Articles

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

France Noizat-Pirenne, MD, PhD, Helene Ansart-Pirenne, MD, PhD, Anne Plonquet, MD, PhD, Philippe Chadebech, PhD, Anoosha Habibi, MD, Dora Bachir, MD, Frederic Galacteros, MD, PhD, Philippe Bierling, MD, PhD

Blood (2005) 106 (11): 954.

https://doi.org/10.1182/blood.V106.11.954.954

Published: 2005

NARROW

Autologous 111 Indium-Oxinate-Labelled Platelet Sequestration Study in Patients with Immune Thrombocytopenia Treated By Thrombopoietic Receptor-Agonists

Portal or Splenic Vein Thrombosis after Splenectomy for Immune Cytopenia: A Retrospective Cohort Study

Impact of Pregnancy On the Course of Immune Thrombocytopenic Purpura: An Observational Study On 44 Cases.

Hydroxychloroquine for the Treatment of Immune Thrombocytopenia Associated with Antinuclear Antibody in Patients Refractory to First-Line treatments .

Costs of Managing Chronic Immune Thrombocytopenic Purpura (ITP) in Adults: A Retrospective Analysis.

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the “real-life” : Result of the French Experience in 72 Adults.

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients: Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

The Organization of the National Blood Bank for Rare Blood Units in France

Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.

Prevalence and Clinical Significance of Elevated Antiphospholipid Antibodies in Adults with Immune Thrombocytopenic Purpura.

Rituximab Is an Alternative to Splenectomy in Adults with Chronic Immune Thrombocytopenic Purpura: Results of a Multicenter Prospective Phase 2 Study.

Relative Immunogenicity of Fy a and K Antigens Based on HLA Class II Restriction Analysis.

A Severe Case of Delayed Haemolytic Transfusion Reaction in a Sickle Cell Disease Patient: Immuno-Haematological Study, Cytokine Transcripts and Lymphocyte Subsets Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only